AIG Horizon Partners Fund

AIG Horizon Partners Fund was a specialized venture capital and private equity vehicle managed by AIG Global Investment Corp, a subsidiary of American International Group. Active primarily during the late 1990s and early 2000s, the fund focused on growth-stage investments within the life sciences, biotechnology, and healthcare sectors. It played a significant role in financing several high-profile biotech companies that later achieved successful clinical milestones, IPOs, or acquisitions. Notable portfolio companies included Eyetech Pharmaceuticals, VaxGen, and Nektar Therapeutics. The fund's investment strategy emphasized innovative therapeutic platforms and companies with late-stage clinical candidates.